Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01090765
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:55.610559+00:00
Published At
2015-02-13T00:00:00+00:00
Record Updated At
2018-05-22
Results Posted At
2015-02-13
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Prostate Cancer", "Metastatic Castrate Resistant Prostate Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-05-22"
protocolSection.identificationModule.nctId
"NCT01090765"
protocolSection.identificationModule.officialTitle
"A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2015-02-13"

Study condition terms

  • Prostate Cancer (protocolSection.conditionsModule.conditions)
  • Metastatic Castrate Resistant Prostate Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.